Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,955 | 6 | 61.3% |
| Travel and Lodging | $5,155 | 11 | 17.6% |
| Consulting Fee | $5,150 | 2 | 17.6% |
| Food and Beverage | $1,023 | 13 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $29,158 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $125.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,901 | 22 | Gilead Sciences, Inc. ($22,776) |
| 2023 | $6,382 | 10 | Gilead Sciences, Inc. ($6,382) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $615.00 | General |
| Category: COVID-19 | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: COVID-19 | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,040.00 | General |
| Category: COVID-19 | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $1,073.05 | General |
| Category: COVID-19 | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $534.02 | General |
| Category: COVID-19 | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $328.87 | General |
| Category: COVID-19 | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $98.30 | General |
| Category: COVID-19 | ||||||
| 10/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,380.00 | General |
| Category: COVID-19 | ||||||
| 10/07/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,380.00 | General |
| Category: COVID-19 | ||||||
| 10/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: COVID-19 | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $446.53 | General |
| Category: COVID-19 | ||||||
| 09/24/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: COVID-19 | ||||||
| 05/02/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $210.00 | General |
| Category: COVID-19 | ||||||
| 04/25/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,040.00 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $367.76 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $198.17 | General |
| Category: COVID-19 | ||||||
| 04/05/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $879.82 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $383.07 | General |
| Category: COVID-19 | ||||||
| 03/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $48.19 | General |
| Category: COVID-19 | ||||||
| 02/23/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: COVID-19 | ||||||
| 02/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $4,940.00 | General |
| Category: COVID-19 | ||||||
| 12/07/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $62.00 | General |
| Category: COVID-19 | ||||||
| 12/01/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: COVID-19 | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 68 | 116 | $28,528 | $9,665 |
| 2022 | 3 | 58 | 105 | $24,828 | $7,655 |
| 2021 | 4 | 72 | 113 | $48,187 | $9,769 |
| 2020 | 5 | 170 | 247 | $124,695 | $22,355 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 65 | $17,726 | $6,062 | 34.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 35 | $6,470 | $2,169 | 33.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 16 | $4,332 | $1,434 | 33.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 71 | $17,750 | $5,423 | 30.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $3,598 | $1,135 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 20 | $3,480 | $1,097 | 31.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 58 | $23,950 | $4,607 | 19.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 16 | $11,479 | $2,455 | 21.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 20 | 20 | $9,452 | $1,643 | 17.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 19 | $3,306 | $1,064 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 55 | 131 | $58,557 | $10,622 | 18.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 42 | 43 | $27,090 | $3,559 | 13.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 21 | $14,952 | $3,255 | 21.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 21 | 21 | $14,238 | $3,129 | 22.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 31 | 31 | $9,858 | $1,789 | 18.1% |
About Dr. Ankur Segon, M.D
Dr. Ankur Segon, M.D is a Internal Medicine healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326248444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankur Segon, M.D has received a total of $29,283 in payments from pharmaceutical and medical device companies, with $22,901 received in 2024. These payments were reported across 32 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,955).
As a Medicare-enrolled provider, Segon has provided services to 368 Medicare beneficiaries, totaling 581 services with total Medicare billing of $49,444. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hospitalist
- Location Milwaukee, WI
- Active Since 07/18/2007
- Last Updated 09/14/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326248444
Products in Payments
- Veklury (Drug) $29,158
- XARELTO (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Milwaukee
Dr. Jeremiah Depta, M.d, M.D
Internal Medicine — Payments: $686,844
Dr. Binod Dhakal, Md, MD
Internal Medicine — Payments: $605,281
Dr. Lee Biblo, Md, MD
Internal Medicine — Payments: $382,388
Dr. Daniel Stein, M.d, M.D
Internal Medicine — Payments: $348,496
Nirav Shah, Md, MD
Internal Medicine — Payments: $280,591
Gilbert Jenouri, M.d, M.D
Internal Medicine — Payments: $229,172